Fox Chase Cancer Center News

A new paper published by researchers at Fox Chase Cancer Center highlights the case of a patient who was diagnosed with adenoid cystic carcinoma (ACC) after a molecular panel identified the presence of an atypical fusion gene.

Physicians at Fox Chase Cancer Center have now performed 10,000 surgeries using the da Vinci robotic surgical system, which has been essential in expanding access to the latest treatment options for cancer patients across multiple cancer specialties.

Andrea Califano, Dr, a leader in the field of systems biology, was recognized today at Fox Chase Cancer Center with the Stanley P. Reimann Honor Award, the center’s highest distinction.

The Cancer Epigenetics Institute (CEI) at Fox Chase Cancer Center recently selected two graduate students for its inaugural Graduate Student Fellowship Awards.

New research by a Fox Chase Cancer Center physician shows that DIEP flap surgery is extremely safe, with a low rate of readmission and complications.

Patients with metastatic colorectal cancer who were treated with a biweekly dose of trifluridine-tipiracil (TAS-102) saw similar treatment effectiveness and reduced toxicity compared with treatment using standard dosing schedules, according to a recent study in The Oncologist that was co-authored by a Fox Chase Cancer Center physician.

The process of DNA amplification, the increase in the number of copies of a gene, has long been known to play a role in cancer and other diseases. More recently, research has focused on regulating this process for therapeutic benefit. Now, scientists at Fox Chase Cancer Center have “connected the dots” with a new paper that reviews decades of research and DNA amplification discoveries.

Joseph Van Galen, MD, MS, Chief Fellow in the Hematology/Oncology Fellowship Program at Fox Chase Cancer Center, was honored today with the American Society of Clinical Oncology’s (ASCO) Conquer Cancer Young Investigator Award.